PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation.
Cheng CF, Ku HC, Lin H. · 2018
Read PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation. by Cheng CF, Ku HC, Lin H. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6274980.txt.
Introduction
Cheng, Ku, and Lin review PGC-1 alpha, a master switch for energy use in the body. Their review appeared in the International Journal of Molecular Sciences. The protein turns on genes for fat burning and energy making. It also guides growth of mitochondria, the cell's power plants. Muscle, liver, fat, heart, and kidney all depend on it.
Newer work links the switch to muscle signals that reach the whole body. It also affects how mitochondria join and split. In kidney injury, its level tracks how well the organ recovers. In cancer its role splits in two. It can suppress some tumours and feed others. The review gathers these roles organ by organ. The picture shows one switch at the centre of body metabolism.
Catalog record
| CREATOR | Cheng CF, Ku HC, Lin H. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 89 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation By Ching-Feng Cheng, Hui-Chen Ku, Heng Lin Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms19113447 ABSTRACT Abstract Traditionally, peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a 91 kDa transcription factor, regulates lipid metabolism and long-chain fatty acid oxidation by upregulating the expression of several genes of the tricarboxylic acid cycle and the mitochondrial fatty acid oxidation pathway. In addition, PGC-1α regulates the expression of mitochondrial genes to control mitochondria DNA replication and cellular oxidative metabolism. Recently, new insights showed that several myokines such as irisin and myostatin are epigenetically regulated by PGC-1α in skeletal muscles, thereby modulating systemic energy balance, with marked expansion of mitochondrial volume density and oxidative capacity in healthy or diseased myocardia. In addition, in our studies evaluating whether PGC-1α overexpression in epicardial adipose tissue can act as a paracrine organ to improve or repair cardiac function, we found that overexpression of hepatic PGC-1α increased hepatic fatty acid oxidation and decreased triacylglycerol storage and secretion in vivo and in vitro. In this review, we discuss recent studies showing that PGC-1α may regulate mitochondrial fusion–fission homeostasis and affect the renal function in acute or chronic kidney injury. Furthermore, PGC-1α is an emerging protein with a biphasic role in cancer, acting both as a tumor suppressor and a tumor promoter and thus representing a new and unresolved topic for cancer biology studies. In summary, this review paper demonstrates that PGC-1α plays a central role in coordinating the gene expression of key components of mitochondrial biogenesis and as a critical metabolic regulator in many vital organs, including white and brown adipose tissue, skeletal muscle, heart, liver, and kidney. Keywords: PGC-1α, metabolic homeostasis, adipose tissue, mitochondria 1. INTRODUCTION The peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family includes ligands of multiple nuclear or non-nuclear receptors that control the expression of specific genes regulating cell metabolism. The first discovered member of the PGC-1 family, a 91 kDa nuclear protein [1] identified in brown adipose tissue (BAT) in mouse studies of cold-induced thermogenesis, was called peroxisome proliferator-activated receptor gamma (PPARγ) coactivator 1α (PGC-1α) [2]. The biological activity of PGC-1α is tightly controlled at several levels: by transcriptional control (of multiple promoter regions), alternative splicing of transcripts, and post-translational modification (e.g., phosphorylation, acetylation, or methylation). This activity results in several mRNA isoforms—PGC-1α-a, PGC-1α-b, PGC-1α-c, and NTPGC-1α—that enable cellular adaptation to various environmental conditions [3]. Studies have shown that PGC-1α can be used in different tissues with different coactivators to induce changes in lipid oxidation, energy homeostasis, mitochondrial mass, and insulin sensitivity. Here, we review these studies. 2. PGC-1Α CAN REGULATE LIPID METABOLISM As a transcription factor, PGC-1α can bind to targets such as PPARα, PPARβ/δ, and PPARγ, which coordinate the expression of mitochondrial genes and indirectly contribute to fatty acid (FA) transport and utilization [4]. Furthermore, PGC-1α upregulates the expression of several genes of the tricarboxylic acid cycle [5] and the mitochondrial FA oxidation pathway [6]. PGC-1α also regulates the expression of nuclear and mitochondrial genes that encode components of the electron transport system and oxidative phosphorylation (OXPHOS) via nuclear respiratory factors 1 and 2 (NRF-1 and -2) and estrogen-related receptor α (ERRα) coactivation. These effects can increase the expression of mitochondrial transcription factor A (mtTFA), which is known to control mtDNA replication and transcription and therefore regulate cellular oxidative metabolism [7]. Accordingly, the augmented expression of cytochrome c, cytochrome-c-oxidase subunits II and IV, and adenosine triphosphate (ATP) synthase also result from PGC-1α activation [8,9,10,11]. Another noteworthy effect of PGC-1α is its ability to stimulate peroxisomal activity such as the oxidation of long-chain and very-long-chain FAs [12]. Briefly, PGC-1α level is positively correlated with the ability of cells to fully oxidize FA, an effect that may reduce intramuscular lipid deposition and improve tissue insulin sensitivity. Chromatin immunoprecipitation assays have shown that the mechanism of this effect includes the coactivation of liver X receptor α (LXRα), which stimulates PGC-1α binding to the LXR response element in the FAS promoter. In addition, muscle-specific PGC-1α expression in MPGC-1α transgenic mice exacerbated de novo free fatty acid (FFA) synthesis as well as FA esterification and triacylglycerol (TAG) accumulation [13]. Furthermore, PGC-1α is involved in lipid distribution and may upregulate FAT/CD36, FABPpm, and FATP1 mRNA and protein expression in mitochondrial fractions. The latter effect was confirmed solely in murine FAT/CD36 and FABP3 cells [14]. 3. PGC-1Α AS A COACTIVATOR FOR METABOLIC HOMEOSTASIS IN SKELETAL MUSCLE Muscle adjusts to endurance exercise by promoting mitochondrial biogenesis, angiogenesis, and changes of fiber composition [15,16,17]. Chinsomboona et al., had reported that mice lacking PGC-1α in skeletal muscle failed to increase capillary density in response to exercise. This study showed that β-adrenergic stimulation of a PGC-1 α/estrogen-related receptor alpha (ERRα)/vascular endothelial growth factor (VEGF) axis modulates exercise-induced angiogenesis in skeletal muscle [18] and truncated PGC-1α can lead to hypoxic induction of VEGF and angiogenesis in skeletal muscle [19]. In addition, PGC-1α activates transcription in cooperation with myocyte enhancer factor-2 (Mef2) and acts as a target for calcineurin signaling, which has been involved in slow fiber gene expression [20]. Skeletal muscle-specific PGC-1α knock-out mice demonstrate a shift from oxidative type I and IIa toward type IIx and IIb glycolytic muscle fibers [21]. Rasbach et al., reported that PGC-1α–mediated switch to slow, oxidative fibers in vitro is dependent on hypoxia-inducible factor 2 α (HIF2α), and mice lacking HIF2α in muscle increase the expression of genes and proteins related to a fast-twitch-fiber-type switch [22]. Transgenic mice with mildly elevated muscle levels of PGC1α are also resistant to age-related obesity and diabetes and show a prolonged lifespan [23]. These results strongly suggest that PGC1α expression in skeletal muscles can significantly contribute to regulating systemic energy balance. Recent studies also demonstrated that muscle contraction may induce the secretion of molecules called myokines, which enables the crosstalk between skeletal muscle and other organs such as adipose tissue, bone, liver, kidney, and brain; in this sense, skeletal muscle can be considered an endocrine organ. Indeed, several myokines discovered in the past decade via secretome analysis include interleukin-6, irisin/fibronectin type III domain-containing protein 5 (FNDC5), myostatin, interleukin-15, brain-derived neurotrophic factor (BDNF), β-aminoisobutyric acid, meteorin-like, leukemia inhibitory factor, and secreted protein acidic and rich in cysteine (SPARC). Several myokines are regulated by PGC-1: irisin/FNDC5, myostatin, and BDNF [24]. (1) Irisin is a PGC-1α-dependent myokine. In mice with muscle-specific PGC-1α overexpression, PGC-1α induces the expression of a membrane protein, FNDC5, and exercise triggers the cleavage of FNDC5 to generate irisin and then secreted into the bloodstream, which elevates energy expenditure in subcutaneous adipose tissue via adipocyte browning [25]. This process implies that PGC-1α overexpression with exercise may increase the expression of uncoupling protein 1 (UCP-1) and eventually increase the browning of white fat cells [25]. Recently, mass spectrometry was used to measure circulating irisin levels in humans in an antibody-independent manner; irisin levels were increased by both short and prolonged period exercise [26,27]. Under physiological conditions, irisin stimulates glucose uptake and lipid metabolism via the activation of AMP-activated protein kinase (AMPK) [28,29,30] and is also involved in muscle growth by inducing insulin-like growth factor 1 and suppressing myostatin [31]. In addition to having effects on muscle, exogenous administration of irisin induces adipocyte browning in